menu search

Cara therapeutics to announce second quarter 2023 financial results on august 7, 2023

STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new...

July 24, 2023, 7:00 am

Cara therapeutics faces uncertainty despite potential reimbursement extension for korsuva

Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney dise...

July 14, 2023, 5:11 pm

Kapruvia® (difelikefalin) recommended by england’s nice for the treatment of adults with moderate-to-severe ckd-associated pruritus

Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chro...

May 18, 2023, 6:00 am

Cara therapeutics to announce first quarter 2023 financial results on may 15, 2023

STAMFORD, Conn., May 01, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new ...

May 1, 2023, 11:00 am

Cara therapeutics announces results from the komfort phase 2 trial of oral difelikefalin for the treatment of pruritus in notalgia paresthetica published in the new england journal of medicine

Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment STAMFORD, Conn., Feb. 08...

February 8, 2023, 10:00 pm

Why trevi therapeutics shares trading higher today?

Trevi Therapeutics Inc (NASDAQ: TRVI) has announced positive results from its Phase 2b/3 PRISM trial of Haduvio in treating prurigo nodularis, a ch...

June 29, 2022, 8:44 am

Cara therapeutics to announce fourth quarter and full year 2021 financial results on march 1, 2022

STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leadin...

February 22, 2022, 4:01 pm

Cara therapeutics to announce fourth quarter and full year 2021 financial results on march 1, 2022

STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leadin...

February 22, 2022, 4:01 pm

Cara therapeutics to announce fourth quarter and full year 2021 financial results on march 1, 2022

STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leadin...

February 22, 2022, 4:01 pm


Search within

Pages Search Results: